Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Tirzepatide for Sale > Pharma grade 99% Purity Retatrutide Peptide 10/15/20/30mg Vials
Pharma grade 99% Purity Retatrutide Peptide 10/15/20/30mg Vials buy - large image1
Pharma grade 99% Purity Retatrutide Peptide 10/15/20/30mg Vials buy - image1
Pharma grade 99% Purity Retatrutide Peptide 10/15/20/30mg Vials buy - image2
Pharma grade 99% Purity Retatrutide Peptide 10/15/20/30mg Vials buy - image3
Pharma grade 99% Purity Retatrutide Peptide 10/15/20/30mg Vials buy - image4
Pharma grade 99% Purity Retatrutide Peptide 10/15/20/30mg Vials buy - image5
Pharma grade 99% Purity Retatrutide Peptide 10/15/20/30mg Vials buy - image6

Pharma grade 99% Purity Retatrutide Peptide 10/15/20/30mg Vials

2047 Inquiries

Unit Price:

$68-76/MT FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

lianyi

Packaging:

30mg/vial; 10vials/box

Price valid (until):

2026-09-20

Company Type:
Distributor
Location:
China
Qualification:
Main Products:

GLP-1,Retatrutide,Selank,Tirzepatide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Sales manager:Lily
    whatsapp:+85257230249
    Email:emma@lianyi-tech.cn

    Items Specifications
    Appearance White powder
    CAS No. 2381089-83-2
    Shelf Life  2 Years

    Product Detail 

    Retatrutide  is a novel peptide-based drug under investigation for its potential in treating obesity and type 2 diabetes. It is a dual GLP-1 and GIP receptor agonist. GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide) are hormones that play key roles in regulating blood sugar levels, appetite, and weight control. By targeting both of these receptors, Retatrutide aims to provide more effective metabolic regulation.  than treatments that focus on only one receptor.Shop Tirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide Wholesale-Detailed Image 1 Shop Tirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide Wholesale-Detailed Image 2

    Product function 

    Retatrutide is a new weight loss drug being experimented on by Eli Lilly, a pharmaceutical giant renowned for its breakthrough in diabetes and obesity treatment. Much like other weight loss drugs rolled out by Eli Lilly, Retatrutide is administered under the skin (subcutaneous route) per week and has yielded exceptional results in treating chronic diseases like diabetes and obesity compared to the predecessors.

    1. 1.Treatment of depression and anxiety disorders:   Retatrutide   has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
    2. 2.Prevention of neurodegenerative diseases:   Retatrutide   has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
    3. 3.Enhancement of cognitive function:  Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
    4. 4.Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
    5. 5.Promotion of wound healing:   Retatrutide has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans. Shop Tirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide Wholesale-Detailed Image 4
    6.  

         Product Application

      • 1.Retatrutide is often used in the pharmaceutical industry, weight losing, etc.
        2.Retatrutide is a kind of peptide product.
        3.Retatrutide acetate can inhibited GCGR, GIPR and GLP-1R.
        4.Retatrutide acetate is activated by glucagon receptors resulting in significant weight loss and increased energy expenditure.
        5.Retatrutide acetate can be used in studies of obesity.

         

        Peptide Storage Guidelines: General Tips

        When storing peptides, remember to:
        • Store peptide in a cold, dry, dark place
        • Avoid repeated freezing and thawing of peptide
        • Avoid overexposure to the air
        • Avoid light exposure
        • Avoid storing peptides in solution long term
        • Aliquot peptide according to experimental requirements

      •  

          Company Profile

          Our company is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. Our factory covers an area of 95 acres, the proposed construction of the plant will be GMP standards, the factory environment clean and tidy, rational layout, with large and medium-sized production workshop and repocessed shop. It is equipped with advanced equipment quality inspection and research center. Those products of both quality and technical content have reached the domestic advanced level. Since its establishment, the company has attached great importance to the team training and technical reform. Our modern production equipment guarantees for a fast and effective production with a superior degree of accuracy throughout the whole production line, everything is done in-house, processing, extraction, packaging and transportation of all links, ensuring maximum quality and efficiency. We are constantly research and development new ingredients and innovative new products, have earned the respect & Admiration from the worldwide customers. After years of continuous development, company has been accumulated rich experience in international trade and customer resources, established a stable customer base and perfect marketing service network. In addition, the company has established long-term technical cooperation with experts and professors from many universities and research institutes in the province.Shop Tirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide Wholesale-Detailed Image 5 Shop Tirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide Wholesale-Detailed Image 6 Shop Tirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide Wholesale-Detailed Image 7 Shop Tirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide Wholesale-Detailed Image 8


           Why choose us?   

        Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 8
    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Other Chemical Drugs

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Distributor

    Main Products:

    GLP-1,Retatrutide,Selank,Tirzepatide

    Location:

    Room 704#-A010, Building 11, Block 16, Liangzhu Street, Yuhang District, Hangzhou City, Zhejiang Province

    Average lead Time:

    1

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

  • Inquiry History
    2047 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    United Kingdom

    tirzepatide

    10 MG Oct 21, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.